JP Morgan Chase
PRVA icon

JP Morgan Chase’s Privia Health PRVA Stock Holding History

JP Morgan Chase’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.71M Sell
178,843
-8,250
-4% -$191K ﹤0.01% 3508
2026
Q1 		$3.75M Buy
187,093
+65,076
+53% +$1.47M ﹤0.01% 3594
2025
Q4 		$2.89M Sell
122,017
-26,692
-18% -$650K ﹤0.01% 3796
2025
Q3 		$3.7M Buy
148,709
+30,845
+26% +$664K ﹤0.01% 3619
2025
Q2 		$2.71M Sell
117,864
-301,442
-72% -$6.98M ﹤0.01% 3680
2025
Q1 		$9.41M Buy
419,306
+20,568
+5% +$478K ﹤0.01% 2593
2024
Q4 		$7.8M Buy
398,738
+210,354
+112% +$4.17M ﹤0.01% 2939
2024
Q3 		$3.43M Buy
188,384
+14,641
+8% +$279K ﹤0.01% 3517
2024
Q2 		$3.02M Sell
173,743
-176,799
-50% -$3.13M ﹤0.01% 3437
2024
Q1 		$6.87M Buy
350,542
+99,110
+39% +$2.09M ﹤0.01% 2813
2023
Q4 		$5.79M Sell
251,432
-876
-0.3% -$19.6K ﹤0.01% 2959
2023
Q3 		$5.8M Buy
252,308
+68,923
+38% +$1.75M ﹤0.01% 2718
2023
Q2 		$4.79M Buy
183,385
+33,346
+22% +$881K ﹤0.01% 2901
2023
Q1 		$4.14M Buy
150,039
+17,973
+14% +$474K ﹤0.01% 2981
2022
Q4 		$3M Sell
132,066
-10,073
-7% -$280K ﹤0.01% 3247
2022
Q3 		$4.84M Sell
142,139
-51,906
-27% -$1.92M ﹤0.01% 2771
2022
Q2 		$5.65M Buy
194,045
+160,206
+473% +$4.07M ﹤0.01% 2684
2022
Q1 		$905K Buy
33,839
+12,732
+60% +$301K ﹤0.01% 4345
2021
Q4 		$546K Buy
21,107
+3,603
+21% +$89.8K ﹤0.01% 4772
2021
Q3 		$413K Sell
17,504
-293
-2% -$10.2K ﹤0.01% 4838
2021
Q2 		$790K Buy
+17,797
New +$657K ﹤0.01% 4431

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

JP Morgan Chase's PRVA Position: Q2 2026 in Review

JP Morgan Chase reduced its Privia Health (PRVA) stake by 4.4% in Q2 2026, selling an estimated $191K and leaving 178,843 shares worth $4.71M. The position accounts for ﹤0.01% of the portfolio, ranked #3508.

JP Morgan Chase first reported a position in PRVA in Q2 2021 and has held it in 21 quarters since. The position peaked at $9.41M in Q1 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • JP Morgan Chase held 178,843 shares of Privia Health worth $4.71M as of Q2 2026.
  • JP Morgan Chase sold 8,250 Privia Health shares in Q2 2026, an estimated $191K.
  • Privia Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3508 holding.
  • JP Morgan Chase first reported a position in Privia Health in Q2 2021 and has held it in 21 quarters since.
  • JP Morgan Chase's Privia Health position peaked at $9.41M in Q1 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.